Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 1
2006 3
2008 2
2009 1
2012 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Supplementum 272: Abstracts of the Annual meeting of the Swiss Society of Gastroenterology, the Swiss Society of Visceral Surgery, the Swiss Association for the Study of the Liver and the Swiss Society of Endoscopy Nurses and Associates.
Swiss Society of Gastroenterology; Swiss Society of Visceral Surgery; Swiss Association for the Study of the Liver; Swiss Society of Endoscopy Nurses and Associates. Swiss Society of Gastroenterology, et al. Swiss Med Wkly. 2023 Sep 11;153(Suppl. 272). doi: 10.57187/s.3511. Swiss Med Wkly. 2023. PMID: 37769146 Free article. No abstract available.
Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis.
Meyer-Wyss B, Rich P, Egger H, Helbling B, Müllhaupt B, Rammert C, Gonvers JJ, Oneta C, Criblez D, Rossi L, Borovicka J, Meyenberger C, Arn M, Renner EL; Swiss Association for the Study of the Liver (SASL). Meyer-Wyss B, et al. J Viral Hepat. 2006 Jul;13(7):457-65. doi: 10.1111/j.1365-2893.2005.00709.x. J Viral Hepat. 2006. PMID: 16792539 Clinical Trial.
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C.
August-Jörg BS, Borovicka J, Dufour JF, Gonvers JJ, Henz S, Hermann R, Meyenberger C, Weitz M, Renner EL; Swiss Association for the Study of the Liver. August-Jörg BS, et al. Swiss Med Wkly. 2003 Aug 23;133(33-34):455-60. doi: 10.4414/smw.2003.10300. Swiss Med Wkly. 2003. PMID: 14625812 Free article. Clinical Trial.
HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin.
Helbling B, Jochum W, Stamenic I, Knöpfli M, Cerny A, Borovicka J, Gonvers JJ, Wilhelmi M, Dinges S, Müllhaupt B, Esteban A, Meyer-Wyss B, Renner EL; Swiss Association for the Study of the Liver (SASL). Helbling B, et al. J Viral Hepat. 2006 Nov;13(11):762-9. doi: 10.1111/j.1365-2893.2006.00753.x. J Viral Hepat. 2006. PMID: 17052276 Clinical Trial.